| Literature DB >> 31269009 |
Zuoguan Chen1,2, Lidan Chen2,3, Jun Zhang4, Yuexin Chen2,5, Changwei Liu2,5, Yongpeng Diao1,2, Yuqing Miao1,2, Qing Gao1,2, Yongjun Li1,2.
Abstract
BACKGROUND We discuss the presentation and management of extracranial carotid artery aneurysms (ECAAs) and to develop a new type of classification. MATERIAL AND METHODS A retrospective review of 35 ECAAs patients who were admitted in our institution from January 2010 to June 2016 was conducted. The mean follow-up period was 25.58±22.13 months. RESULTS During the study period, 35 aneurysms were diagnosed and treated (mean age, 50.8±15.6 years; 15 men). There were 28 true aneurysms, 5 false aneurysms, and 2 dissecting aneurysms. A total of 16 patients with true aneurysms underwent open surgical treatment (group 1), whereas 15 received endovascular management, including all false and dissecting aneurysms (group 2). The remaining 4 true aneurysms were treated with hybrid operation (group 3). The patency rates of groups 1, 2, and 3 were 100%, 93.3%, and 100%, respectively. According to the Peking Union Medical College Hospital (PUMCH) Classification, all 24 cases of type Ia aneurysms were treated by either open surgery and/or endovascular treatment, whereas all 3 type Ib cases were treated solely by open surgery. All 5 type IIa patients were treated by endovascular treatment, with the exception of 1 failure that was transferred to hybrid operation. All 3 type IIb patients were treated by hybrid operation. CONCLUSIONS Open surgery was more frequently feasible in true aneurysms, and endovascular surgery was the first choice for false and dissecting aneurysms. Hybrid operation was available for complicated cases. The PUMCH classification may be helpful for selection of management strategies for ECAAs.Entities:
Year: 2019 PMID: 31269009 PMCID: PMC6621797 DOI: 10.12659/MSM.914374
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Patients’ demographic data and comorbidities.
| Open surgery (n=16) | Endovascular (n=15) | Hybrid (n=4) | Total (n=35) | |
|---|---|---|---|---|
| Age, mean ±SD (years) | 50.25±14.64 | 49.07±16.81 | 60±15.68 | 50.8±15.62 |
| Male, sex | 5 (31%) | 9 (60%) | 1 (25%) | 15 (43%) |
| Smoker or past smoker | 3 (19%) | 1 (7%) | 0 (0%) | 4 (11%) |
| Hypertension | 5 (31%) | 5 (33%) | 2 (50%) | 12 (34%) |
| Diabetes | 0 (0%) | 1 (7%) | 0 (0%) | 1 (3%) |
| Hyperlipaemia | 0 (0%) | 1 (7%) | 1 (25%) | 2 (6%) |
| Coronary artery disease | 2 (13%) | 1 (7%) | 1 (25%) | 4 (11%) |
| Cerebrovascular disease | 2 (13%) | 3 (20%) | 1 (25%) | 6 (17%) |
| Peripheral arterial disease | 0 (0%) | 2 (13%) | 0 (0%) | 2 (6%) |
| Symptoms | ||||
| Mass | 9 (56%) | 8 (53%) | 3 (75%) | 20 (57%) |
| Pain | 4 (25%) | 4 (27%) | 0 (0%) | 8 (23%) |
| TIA/stroke | 5 (31%) | 6 (40%) | 3 (75%) | 14 (40%) |
| Nerve compression | 1 (6%) | 3 (20%) | 1 (25%) | 5 (14%) |
SD – standard deviation; TIA – transient ischemic attack.
Classification of aneurysm (attigah, structure).
| Open surgery (n=16) | Endovascular (n=15) | Hybrid (n=4) | ||
|---|---|---|---|---|
| Attigah | I | 4 | 4 | 0 |
| II | 1 | 2 | 0 | |
| III | 2 | 1 | 0 | |
| IV | 4 | 3 | 4 | |
| V | 5 | 5 | 0 | |
| Structure | TRUE | 16 | 8 | 4 |
| FALSE | 0 | 5 | 0 | |
| Dissecting | 0 | 2 | 0 |
Type I, aneurysm of the internal carotid artery distal to the carotid bifurcation; type II, aneurysm of the internal carotid artery; type III, aneurysm of the carotid bifurcation; type IV, aneurysm of the internal carotid artery and the common carotid artery; type V, aneurysm of the common carotid artery.
Figure 1PUMCH classification. Type Ia: aneurysm below the line of Blaisdell in the absence of kinking; Type Ib: aneurysm below the line of Blaisdell in the presence kinking; Type IIa: aneurysm up to the line of Blaisdell in the absence of kinking; Type IIb: aneurysm up to the line of Blaisdell in the presence of kinking.
Figure 2Typical cases of PUMCH classification. (A, B) Open surgery for type Ia; (C, D) Endovascular treatment for type Ia; (E, F) Open surgery for type Ib; (G, H) Endovascular treatment for type IIa; (I, J) Hybrid operation for type IIb.
General conditions, arterial lesions, surgical procedures and follow-up results.
| Case no. | Surgical technique | Medical treatment | Complication | Follow up | Patency | ||
|---|---|---|---|---|---|---|---|
| Pre | Post | Early | Late | Duration (m) | |||
| 1 | ABV | AC | AC | – | – | 2.9 | Patent |
| 2 | VG | AP | AP | RLNp | – | 45.9 | Patent |
| 3 | VG | AP | AP | – | – | 39.6 | Patent |
| 4 | VG | AP | AP | HGNp | – | 44.1 | Patent |
| 5 | VG | AP | AP+AC | FNp+hematoma | – | 12.5 | Patent |
| 6 | VG | AP | AP | RLNp+ HGNp | – | 38.1 | Patent |
| 7 | AVB | AP | AC | – | – | 8.3 | Patent |
| 8 | REE | AP | AP | HGNp | – | 18.8 | Patent |
| 9 | REE | AP | AP | Stroke+hematoma | – | 22.4 | Patent |
| 10 | REE | AP | AP | – | – | 75.2 | Patent |
| 11 | REE | AP | AP | – | – | 77.7 | Patent |
| 12 | VG | AP | AP | RLNp | – | 53 | Patent |
| 13 | AVB | AP | AP | – | – | 75 | Patent |
| 14 | REE | AP | AP+AC | – | – | 62.7 | Patent |
| 15 | VG | AP | AC | – | – | 2.8 | Patent |
| 16 | REE | AP | AP | – | – | 13.1 | Patent |
| 17 | Nr | AP | AP | – | – | 8.5 | Patent |
| 18 | Viabahn (7–50 mm) | AP | AC | – | – | 12.8 | Patent |
| 19 | Viabahn (7–50 mm) | AP | AP+AC | – | – | 11.3 | Patent |
| 20 | Viabahn (8–100 mm) | AP | AP+AC | – | – | 17.6 | Patent |
| 21 | Viabahn (8–50 mm) | AP | AC | – | – | 35.3 | Patent |
| 22 | Nr | AP | AP | – | – | 5 | Patent |
| 23 | Viabahn (9–100 mm) | AP | AP+AC | – | – | 21.5 | Patent |
| 24 | Viabahn (6–8–40 mm)+Coil | AP | AP | – | – | 6.4 | Patent |
| 25 | Viabahn (6–50 mm, 8–100 mm)+Coil | AP | AC | – | – | 7.2 | Patent |
| 26 | Acculink (6–8–40 mm) | AP | AP+AC | – | – | 13.6 | Patent |
| 27 | Coil | AP | AP | – | – | 36.2 | Patent |
| 28 | Coil | AP | AP | – | – | 14.4 | Patent |
| 29 | Viabahn (6–50 mm) | AP | AP+AC | – | – | 16.8 | Reoperation |
| 30 | Nr | AP | AP | – | – | 37.6 | Patent |
| 31 | Acculink (6–8–40 mm)+Coil | AP | AP | – | – | 32.7 | Patent |
| 32 | Viabahn (5–100 mm)+ES | AP | AP+AC | Stroke | – | 8.5 | Patent |
| 33 | Viabahn (6–50 mm, 5–50 mm)+REE | AP | AP | HGNp | – | 2.6 | Patent |
| 34 | Viabahn (6–100 mm)+ABV+ES | AP | AP+AC | – | – | 4.5 | Patent |
| 35 | Viabahn (5–50 mm) | AP | AP+AP | – | – | 10 | Patent |
VG – vein graft; REE – resection and end-to-end anastomosis; EE – end-to-end anastomosis; ABV – artificial blood vessel; ES – end-to-side anastomosis; AP – antiplatelet; AC – anti-coagulant; RLNp – recurrent laryngeal nerve palsy; HGNp – hypoglossal nerve palsy; FNp – facial nerve palsy; Nr – no record.
Figure 3The management strategy for the treatment of ECAAs.